Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide
1995
Brogden, K.A. | Chedid, L.
Protection of ruminants against bacterial pneumonia caused by Pasteurella haemolytica has been achieved with a subunit vaccine. The vaccine contains two principle components; capsular polysaccharide of P. haemolytica and a synthetic adjuvant, muramyl dipeptide. This vaccine prevented bacterial infection of the lungs of vaccinated animals upon challenge with P. haemolygica. In contrast, animals that were not vaccinated or animals that were vaccinated with only capsular polysaccharide alone had severe lesions and high concentrations of P. haemolytica in the lung.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
[Washington, D.C.? : The Department, 1900?-
其它主题
Mannheimia haemolytica; Usda; Us005462735a; Animal diseases (bacterial); Bacterial pneumonia; United states; Laws and regulations
语言
英语
注释
Copies of usda patents are available for a fee from the commissioner of patents and trademarks, u.s. patent and trademarks office, washington, d.c., 20231.
Includes references
类型
Text; Monograph; Book
2024-02-27
MODS